Organization
Sanofi Genzyme
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Sanofi Genzyme
... SAN FRANCISCO—Sanofi and Regeneron may have had a hot start in 2017 with Dupixent, ...
... and B. Global commercialization of fitusiran, upon approval, will be done by Sanofi Genzyme, the specialty care global business unit of Sanofi. Alnylam will receive ...
... Chief Executive Officer of Swedish Orphan Biovitrum (Sobi), and previously served as Genzyme's President EMEA, and as General Manager of the Lysosomal Storage Disease franchise ...
... Operating Officer at Synageva BioPharma Corp. Ms. Secor spent 15 years at Genzyme Corporation in diverse leadership roles, most recently as the Global General Manager ...
... Operating Officer at Synageva BioPharma Corp. Ms. Secor spent 15 years at Genzyme Corporation in diverse leadership roles, most recently as the Global General Manager ...
... 2012 to February 2016.Prior to rEVO, Mr. Becker spent 10 years at Genzyme, most recently serving as Finance Director for the UK and Ireland before ...
... under accelerated assessment Paris and Cambridge, Mass. - December 18, 2017 - Sanofi Genzyme, the specialty care global business unit of Sanofi, and Alnylam Pharmaceuticals, ...
... and Global Therapeutic Group Head for Oncology and Personalized Genetic Health at Genzyme Corporation, where he was responsible for leading clinical development teams for all ...
... spent more than 20 years in various positions of increasing responsibility at Genzyme Corporation and subsequently as part of Sanofi, following its 2011 acquisition of ...
... granted accelerated assessment by the European Medicines Agency. Alnylam, in collaboration with Sanofi Genzyme, intends to file a Marketing Authorization Application in the European Union ...
... About 18,000 gel-filled syringes sold by the Cambridge biotech Sanofi Genzyme to treat arthritis of the knee have been recalled because that ...
... opportunity loss for the other monoclonal antibody DMTs, including Genentech's Rituxan and Sanofi Genzyme's Lemtrada, as well as Tysabri. Thus far, Sanofi-Genzyme's Aubagio has been ...
... for a promising treatment option for this disease.' Alnylam, in alliance with Sanofi Genzyme, plans to submit a Marketing Authorisation Application to the European Medicines ...
... once it is in front of the agency. Alnylam, along with partner Sanofi Genzyme, is also working to win approval for patisiran in the rest ...
... Consequently, APPs report not only significantly higher shares of Biogen's Tysabri and Sanofi Genzyme's Lemtrada, but also appear to be early adopters of Roche's Ocrevus ...
... by the end of 2017, where Fast Track Designation has been granted. Sanofi Genzyme is currently preparing for regulatory filings for patisiran in Japan, Brazil ...
... are twice as likely to be hospitalized for a bleeding episode. Alnylam -Sanofi Genzyme AllianceInJanuary 2014, Alnylam and Sanofi Genzyme, the specialty care global business ...
... for PH1. Alnylam - Sanofi Genzyme Alliance In January 2014, Alnylam and Sanofi Genzyme, the specialty care global business unit of Sanofi, formed an alliance ...
... - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Sanofi Genzyme, the specialty care global business unit of Sanofi, announced today positive ...
... survey of 100 US-based neurologists, the report covers 12 major therapies from Genzyme, Biogen, Bayer, Teva, Sanofi, Novartis, Roche, EMD Serono, and AbbVie/Biogen. Top Takeaways ...
... B6 supplementation, there are no approved pharmaceutical therapies for PH1. Alnylam - Sanofi Genzyme AllianceInJanuary 2014, Alnylam and Sanofi Genzyme, the specialty care global business ...
... with Merck at the end of 2016.Q3 2017 sales performance supported by Sanofi Genzyme, Sanofi Pasteur and Emerging Markets - Net sales were EUR9,053 million, ...
Want to see the full history on Sanofi Genzyme? Upgrade to RelSci Pro now!
Start My Free Trial